Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 253 publications
A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor.
Journal: Gynecologic oncology
Published: May 08, 2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 30, 2026
Prognostic comparison of the FIGO 2009 and 2023 endometrial cancer staging systems: a large, single-institution retrospective cohort study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 23, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.
Journal: JCO precision oncology
Published: January 29, 2026
Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: January 12, 2026
Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.
Journal: International journal of radiation oncology, biology, physics
Published: January 12, 2026
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201.
Journal: Future oncology (London, England)
Published: December 12, 2025
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2025
Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 13, 2025
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer.
Journal: Gynecologic oncology
Published: August 01, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 11, 2025
Whole-genome sequencing-based characterization of endometrial serous carcinoma.
Journal: Gynecologic oncology
Published: July 02, 2025
Last Updated: 09/26/2026